These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35310073)

  • 1. SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling.
    Lai DY; Jiang HW; Li Y; Zhang HN; Tao SC
    STAR Protoc; 2022 Jun; 3(2):101238. PubMed ID: 35310073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 spike linear epitope scanning via a peptide microarray through sera profiling.
    Li Y; Lai DY; Tao SC
    STAR Protoc; 2021 Sep; 2(3):100707. PubMed ID: 34308376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins.
    Li Y; Xu Z; Lei Q; Lai DY; Hou H; Jiang HW; Zheng YX; Wang XN; Wu J; Ma ML; Zhang B; Chen H; Yu C; Xue JB; Zhang HN; Qi H; Guo SJ; Zhang Y; Lin X; Yao Z; Sheng H; Sun Z; Wang F; Fan X; Tao SC
    Cell Rep; 2021 Jul; 36(2):109391. PubMed ID: 34242574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape.
    Suryadevara N; Gilchuk P; Zost SJ; Mittal N; Zhao LL; Crowe JE; Carnahan RH
    STAR Protoc; 2022 Jun; 3(2):101387. PubMed ID: 35578733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.
    Jiang HW; Li Y; Zhang HN; Wang W; Yang X; Qi H; Li H; Men D; Zhou J; Tao SC
    Nat Commun; 2020 Jul; 11(1):3581. PubMed ID: 32665645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.
    Cheng L; Zhang X; Chen Y; Wang D; Zhang D; Yan S; Wang H; Xiao M; Liang T; Li H; Xu M; Hou X; Dai J; Wu X; Li M; Lu M; Wu D; Tian R; Zhao J; Zhang Y; Cao W; Wang J; Yan X; Zhou X; Liu Z; Xu Y; He F; Li Y; Yu X; Zhang S
    Signal Transduct Target Ther; 2021 Aug; 6(1):304. PubMed ID: 34404759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
    Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
    Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling.
    Emmenegger M; Worth R; Fiedler S; Devenish SRA; Knowles TPJ; Aguzzi A
    STAR Protoc; 2023 Mar; 4(1):102095. PubMed ID: 36853663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for global proteome, virome, and metaproteome profiling of respiratory specimen (VTM) in COVID-19 patient by LC-MS/MS-based analysis.
    Tripathi G; Sharma N; Bindal V; Yadav M; Mathew B; Sharma S; Gupta E; Singh Maras J; Sarin SK
    STAR Protoc; 2022 Mar; 3(1):101045. PubMed ID: 34870243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative IgG ELISA for detection of SARS-CoV-2-specific antibodies in Syrian hamster serum samples.
    Shete A; Mohandas S; Jain R; Yadav PD
    STAR Protoc; 2021 Jun; 2(2):100573. PubMed ID: 33997801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples.
    Banerjee A; Pai MGJ; Singh A; Nissa MU; Srivastava S
    STAR Protoc; 2022 Mar; 3(1):101177. PubMed ID: 35233542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative immunoassay for the detection of anti-SARS-COV-2 spike antibody in human milk samples.
    Yang X; Fox A; Powell RLR
    STAR Protoc; 2022 Mar; 3(1):101203. PubMed ID: 35284838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19.
    Martin S; Jégou G; Nicolas A; Le Gallo M; Chevet É; Godey F; Avril T
    STAR Protoc; 2022 Mar; 3(1):101229. PubMed ID: 35287269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution.
    Wang H; Wu X; Zhang X; Hou X; Liang T; Wang D; Teng F; Dai J; Duan H; Guo S; Li Y; Yu X
    ACS Cent Sci; 2020 Dec; 6(12):2238-2249. PubMed ID: 33372199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19.
    Ravichandran S; Tang J; Grubbs G; Lee Y; Pourhashemi S; Hussaini L; Lapp SA; Jerris RC; Singh V; Chahroudi A; Anderson EJ; Rostad CA; Khurana S
    Nat Immunol; 2021 Nov; 22(11):1452-1464. PubMed ID: 34611361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol to detect infectious SARS-CoV-2 at low levels using in situ hybridization techniques.
    Cottignies-Calamarte A; He F; Zhu A; Real F; Bomsel M
    STAR Protoc; 2023 Dec; 4(4):102593. PubMed ID: 37738115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.